Indeed, while the role of health in mate preferences is clear , recent work has demonstrated that participants are more willing to reciprocate trust from healthy-looking social partners than from social partners who are relatively unhealthy-looking.
Women and their mothers were strongly influenced by the physical attractiveness of the target men and preferred the attractive and moderately attractive targets. Men with the most desirable personality profiles were rated more favorably than their counterparts only when they were at least moderately attractive. Unattractive men were never rated as more desirable partners for daughters, even when they possessed the most desirable trait profiles.
Results suggest that apparent health of facial skin is correlated both with ratings of male facial attractiveness (experiment 1) and with being a visual cue for judgments of the attractiveness of male faces (experiment 2).
Since fluctuating asymmetry, a measure of developmental stability, is known to be a valid cue for fitness in several biological domains, we scrutinized facial asymmetry as a potential mediator between attractiveness and fitness.
Research also shows that to maximize your attractiveness to women, guys only need to gain about 20 to 30 pounds of muscle and reduce their body fat percentage to 8 to 12%.
Based on research indicating single males have higher testosterone levels than partnered males and that higher testosterone levels are associated with stronger smelling BO, the current study aimed to determine if, by extension of previous findings, single males’ BO smells stronger than partnered males’ BO.
People shown before-and-after pictures of hair transplant recipients rated men with more locks as looking more attractive and younger, researchers found. People also thought the men looked more successful and approachable after the procedure.
In these two studies in men with vertex baldness, significant increases in hair count were demonstrated at 6 and 12 months in men treated with PROPECIA, while significant hair loss from baseline was demonstrated in those treated with placebo.
Patients who switched from placebo to PROPECIA (n=425) had a decrease in hair count at the end of the initial 12-month placebo period, followed by an increase in hair count after 1 year of treatment with PROPECIA. This increase in hair count was less (56 hairs above original baseline) than the increase (91 hairs above original baseline) observed after 1 year of treatment in men initially randomized to PROPECIA.
コメント